| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $8.42 ▲ +2.93% | Yesterday | $8.15 ▲ +0.37% | Tomorrow's Xilio Therapeutics Inc. Common Stock (XLO) setup is anchored to $8.18 and targets $8.42 (+2.93%). The near-term read is upside; watch $9.00 / $8.02 because daily realized volatility is about 3.50%. |
Tomorrow's Xilio Therapeutics Inc. Common Stock (XLO) setup is anchored to $8.18 and targets $8.42 (+2.93%). The near-term read is upside; watch $9.00 / $8.02 because daily realized volatility is about 3.50%. | ||||
| Week | $8.31 ▲ +1.59% | Last Week | $7.76 ▲ +5.41% | The 7-day Xilio Therapeutics Inc. Common Stock model moves from $7.76 to $8.31 (+1.59%). It gives upside momentum context for this stock, so breaks around $9.00 / $8.02 matter more than a single tick. |
The 7-day Xilio Therapeutics Inc. Common Stock model moves from $7.76 to $8.31 (+1.59%). It gives upside momentum context for this stock, so breaks around $9.00 / $8.02 matter more than a single tick. | ||||
| Month | $8.07 ▼ -1.34% | Last Month | $8.45 ▼ -3.20% | The 1-month Xilio Therapeutics Inc. Common Stock target is $8.07 (-1.34%), compared with the live reference near $8.18. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Xilio Therapeutics Inc. Common Stock target is $8.07 (-1.34%), compared with the live reference near $8.18. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $7.72 ▼ -5.62% | Last Year | $12.57 ▼ -34.92% | The 1-year Xilio Therapeutics Inc. Common Stock scenario points to $7.72 (-5.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Xilio Therapeutics Inc. Common Stock scenario points to $7.72 (-5.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $6.91 ▼ -15.53% | 5 Years Ago | $224.00 ▼ -96.35% | The 5-year Xilio Therapeutics Inc. Common Stock view is $6.91 (-15.53%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Xilio Therapeutics Inc. Common Stock view is $6.91 (-15.53%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 1.0 | Bearish |
| MACD | 0.07 | Bullish |
| SMA 50 | $8.13 | Above |
| SMA 200 | $32.64 | Mid |
| EMA 20 | $44.58 | Mid |
| Opening Price | $8.03 | Start Date | 2021-10-22 |
| Day Range | $8.03 – $8.29 | Market Cap | $49.27M |
| Monthly Range | $7.71 – $8.81 | 24h Volume | n/a |
| 90D Range | $7.14 – $9.52 | Circulating | n/a |
| 52W Range | $7.14 – $20.72 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.